XML 26 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statement of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Shares [Member]
Shares Outstanding, Beginning Balance at Dec. 31, 2017   27,856,752      
Stockholders' Equity, Beginning Balance at Dec. 31, 2017 $ 747,298 $ 295 $ 306,483 $ 473,329 $ (32,809)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 75,256     75,256  
Proceeds from issuance of common shares for conversion of convertible notes 20,309 $ 6 20,303    
Common shares issued for conversion of convertible notes   628,515      
Stock options exercised, shares   24,220      
Stock options exercised 426   (56)   482
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3,771   3,771    
Repurchase of common shares, shares   (437,490)      
Repurchase of common shares (11,085)       (11,085)
Deferral of executive and director compensation 184   184    
Deferred Compensation Arrangement with Individual, Shares Issued   61,366      
Deferred Compensation Arrangement with Individual, Distribution Paid (955)   (2,174)   1,219
Shares Outstanding, Ending Balance at Sep. 30, 2018   28,133,363      
Stockholders' Equity, Ending Balance at Sep. 30, 2018 835,204 $ 301 328,511 548,585 (42,193)
Shares Outstanding, Beginning Balance at Jun. 30, 2018   28,570,853      
Stockholders' Equity, Beginning Balance at Jun. 30, 2018 815,966 $ 301 327,470 519,303 (31,108)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 29,282     29,282  
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 1,041   1,041    
Repurchase of common shares, shares   (437,490)      
Repurchase of common shares (11,085)       (11,085)
Shares Outstanding, Ending Balance at Sep. 30, 2018   28,133,363      
Stockholders' Equity, Ending Balance at Sep. 30, 2018 835,204 $ 301 328,511 548,585 (42,193)
Shares Outstanding, Beginning Balance at Dec. 31, 2018   27,516,218      
Stockholders' Equity, Beginning Balance at Dec. 31, 2018 855,303 $ 301 330,517 580,992 (56,507)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 85,807     85,807  
Stock options exercised, shares   710,830      
Stock options exercised 14,348   (1,177)   15,525
APIC, Share-based Payment Arrangement, Increase for Cost Recognition $ 4,086   4,086    
Repurchase of common shares, shares (200,000) (201,088)      
Repurchase of common shares $ (5,150)       (5,150)
Deferral of executive and director compensation 247   247    
Deferred Compensation Arrangement with Individual, Shares Issued   116,956      
Deferred Compensation Arrangement with Individual, Distribution Paid 0   (2,545)   2,545
Shares Outstanding, Ending Balance at Sep. 30, 2019   28,142,916      
Stockholders' Equity, Ending Balance at Sep. 30, 2019 954,641 $ 301 331,128 666,799 (43,587)
Shares Outstanding, Beginning Balance at Jun. 30, 2019   27,617,366      
Stockholders' Equity, Beginning Balance at Jun. 30, 2019 904,240 $ 301 330,052 628,961 (55,074)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 37,838     37,838  
Stock options exercised, shares   525,550      
Stock options exercised 11,071   (416)   11,487
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 1,492   1,492    
Shares Outstanding, Ending Balance at Sep. 30, 2019   28,142,916      
Stockholders' Equity, Ending Balance at Sep. 30, 2019 $ 954,641 $ 301 $ 331,128 $ 666,799 $ (43,587)